Selective inhibition of murine palatal mesenchymal cell proliferation in vitro by secalonic acid D

Umesh M Hanumegowda1, Barbara M Judy, Wade V Welshons

  • 1Department of Veterinary Biomedical Sciences, University of Missouri, 1600 E. Rollins, Columbia, Missouri 65211, USA.

Insights

Secalonic acid D (SAD) causes cleft palate in mice by inhibiting palatal shelf growth. SAD reduces mesenchymal cell proliferation, not cell death or extracellular matrix synthesis, leading to smaller palatal shelves.

Area of Science:

  • Developmental toxicology
  • Cell biology
  • Teratology

Background:

  • Secalonic acid D (SAD) is a mycotoxin known to cause birth defects.
  • Cleft palate (CP) is a common congenital abnormality influenced by environmental factors.
  • Palatal shelf growth is crucial for normal palate development and can be affected by reduced cell proliferation, increased apoptosis, or decreased extracellular matrix (ECM) synthesis.

Purpose of the Study:

  • To investigate the effects of SAD on primary murine palatal mesenchymal cells (PMC).
  • To determine if SAD inhibits cell proliferation, induces apoptosis, or affects ECM synthesis in PMCs at teratogenic concentrations.
  • To elucidate the cellular mechanisms underlying SAD-induced cleft palate.

Main Methods:

  • Primary murine PMC cultures were exposed to varying concentrations of SAD (0 to 120 microg/ml).
  • Cell proliferation was assessed by measuring cell number, (3)H-thymidine uptake, and proliferating cell nuclear antigen (PCNA) expression.
  • Cell death was evaluated using trypan blue dye exclusion and DNA fragmentation assays.
  • ECM synthesis was analyzed by (3)H-glucosamine uptake for hyaluronic acid (HA) and sulfated glycosaminoglycans (sGAG), and fibronectin expression was assessed.

Main Results:

  • SAD exposure caused significant, dose-dependent decreases in PMC number, (3)H-thymidine uptake, and PCNA expression.
  • Significant cell death was observed only at higher SAD doses, and DNA fragmentation assays indicated it was not apoptotic.
  • SAD had minimal impact on HA and sGAG accumulation and did not affect fibronectin expression at any tested dose.

Conclusions:

  • SAD inhibits palatal mesenchymal cell proliferation in a dose-dependent manner.
  • Reduced cell proliferation, rather than apoptosis or altered ECM synthesis, is the primary mechanism for SAD-induced inhibition of palatal shelf growth.
  • These findings clarify the cellular pathogenesis of SAD-induced cleft palate, highlighting the critical role of proliferation inhibition.

Related Concept Videos